A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
Clinical trial NCT04540497 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04540497
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2024-04-09
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.